No statistical differences in DFS between patients with high or low CD8+ T-cell tumor infiltrate (hazard ratio 0.85, 95% CI 0.39–1.88, p = 0.70), high or low FoxP3+ T-cell tumor infiltrate (hazard ratio 1.55, 95% CI 0.73–3.28, p = 0.25), or expression or loss/downregulation of HLA class 1 of tumor cells were found (hazard ratio 1.38, 95% CI 0.61–3.13, p = 0.44). The gene discussed is FOXP3; the disease is neoplasm.